AstraZeneca PLC (STO: AZN)
1,783.50
-4.00 (-0.22%)
Aug 30, 2024, 5:29 PM CET
AstraZeneca Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 6,440 | 5,955 | 3,288 | 112 | 3,196 | 1,335 | Upgrade
|
Depreciation & Amortization | 4,901 | 4,851 | 5,178 | 4,039 | 2,835 | 2,714 | Upgrade
|
Other Amortization | 280 | 280 | 292 | 311 | 61 | 68 | Upgrade
|
Loss (Gain) From Sale of Assets | -64 | -292 | -216 | -509 | -1,055 | -1,243 | Upgrade
|
Asset Writedown & Restructuring Costs | 162 | 456 | 226 | 2,428 | 253 | 980 | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | - | -776 | - | - | Upgrade
|
Loss (Gain) on Equity Investments | 30 | 12 | 5 | 64 | 27 | 116 | Upgrade
|
Stock-Based Compensation | -71 | -71 | 27 | 45 | -72 | -64 | Upgrade
|
Other Operating Activities | -1,076 | -1,146 | -2,749 | -1,772 | -807 | -591 | Upgrade
|
Change in Accounts Receivable | -1,425 | -1,425 | -1,349 | -961 | -739 | -898 | Upgrade
|
Change in Inventory | -669 | -669 | 3,941 | 1,577 | -621 | -316 | Upgrade
|
Change in Accounts Payable | 2,394 | 2,394 | 1,165 | 1,405 | 1,721 | 868 | Upgrade
|
Operating Cash Flow | 11,065 | 10,345 | 9,808 | 5,963 | 4,799 | 2,969 | Upgrade
|
Operating Cash Flow Growth | 8.70% | 5.48% | 64.48% | 24.26% | 61.64% | 13.41% | Upgrade
|
Capital Expenditures | -1,643 | -1,361 | -1,091 | -1,091 | -961 | -979 | Upgrade
|
Sale of Property, Plant & Equipment | 59 | 132 | 282 | 13 | 106 | 37 | Upgrade
|
Cash Acquisitions | -3,734 | -1,099 | -1,035 | -10,117 | -822 | -709 | Upgrade
|
Sale (Purchase) of Intangibles | -2,377 | -2,126 | -1,033 | -522 | -694 | 595 | Upgrade
|
Investment in Securities | -262 | -87 | -143 | 605 | 1,999 | 125 | Upgrade
|
Other Investing Activities | 374 | 477 | 60 | 54 | 87 | 274 | Upgrade
|
Investing Cash Flow | -7,583 | -4,064 | -2,960 | -11,058 | -285 | -657 | Upgrade
|
Short-Term Debt Issued | - | 161 | 74 | - | 288 | - | Upgrade
|
Long-Term Debt Issued | - | 3,816 | - | 12,929 | 2,968 | 500 | Upgrade
|
Total Debt Issued | 7,568 | 3,977 | 74 | 12,929 | 3,256 | 500 | Upgrade
|
Short-Term Debt Repaid | - | - | - | -276 | - | -516 | Upgrade
|
Long-Term Debt Repaid | - | -5,210 | -1,515 | -4,999 | -1,816 | -1,686 | Upgrade
|
Total Debt Repaid | -4,466 | -5,210 | -1,515 | -5,275 | -1,816 | -2,202 | Upgrade
|
Net Debt Issued (Repaid) | 3,102 | -1,233 | -1,441 | 7,654 | 1,440 | -1,702 | Upgrade
|
Issuance of Common Stock | 36 | 33 | 29 | 29 | 30 | 3,525 | Upgrade
|
Common Dividends Paid | -4,462 | -4,481 | -4,364 | -3,856 | -3,572 | -3,592 | Upgrade
|
Other Financing Activities | -887 | -886 | -1,047 | -178 | -101 | 4 | Upgrade
|
Financing Cash Flow | -2,211 | -6,567 | -6,823 | 3,649 | -2,203 | -1,765 | Upgrade
|
Foreign Exchange Rate Adjustments | -65 | -60 | -80 | -62 | 12 | 5 | Upgrade
|
Net Cash Flow | 1,206 | -346 | -55 | -1,508 | 2,323 | 552 | Upgrade
|
Free Cash Flow | 9,422 | 8,984 | 8,717 | 4,872 | 3,838 | 1,990 | Upgrade
|
Free Cash Flow Growth | 4.19% | 3.06% | 78.92% | 26.94% | 92.86% | 26.35% | Upgrade
|
Free Cash Flow Margin | 19.18% | 19.61% | 19.65% | 13.02% | 14.42% | 8.16% | Upgrade
|
Free Cash Flow Per Share | 6.03 | 5.75 | 5.59 | 3.41 | 2.92 | 1.53 | Upgrade
|
Cash Interest Paid | 1,181 | 1,081 | 849 | 721 | 733 | 774 | Upgrade
|
Cash Income Tax Paid | 2,642 | 2,366 | 1,623 | 1,743 | 1,562 | 1,118 | Upgrade
|
Levered Free Cash Flow | 9,823 | 9,499 | 12,610 | -1,845 | 3,441 | 6,213 | Upgrade
|
Unlevered Free Cash Flow | 10,423 | 10,061 | 12,968 | -1,608 | 3,902 | 6,701 | Upgrade
|
Change in Net Working Capital | -1,166 | -1,517 | -3,586 | 6,523 | 347 | -2,126 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.